Anthem Biosciences Limited
Annual Financials 2023
2024
2025
TTM
Revenue 1,134
1,488
1,841
0
Expenses 628
913
1,152
0
EBITDA 506
575
689
0
Operating Profit % 41 %
36 %
37 %
0 %
Depreciation 64
82
78
0
Interest 7
9
9
0
Profit Before Tax 498
485
711
0
Tax 112
110
182
0
Net Profit 386
375
529
0
EPS in ₹ 6.76
6.61
9.05
0.00
Above figures are in Rs. Crores Balance Sheet 2023
2024
2025
Total Assets 1,993
2,324
2,836
Fixed Assets 449
478
682
Current Assets 1,320
1,446
1,664
Capital Work in Progress 143
156
58
Investments 499
472
339
Other Assets 902
1,219
0
Total Liabilities 1,993
2,324
2,836
Current Liabilities 153
302
291
Non Current Liabilities 99
89
71
Total Equity 1,742
1,933
2,473
Reserve & Surplus 1,628
1,821
2,361
Share Capital 114
112
112
Above figures are in Rs. Crores Cash Flow 2021
2022
2023
Net Cash Flow 18
308
-6
Investing Activities -196
-205
-376
Operating Activities 278
333
306
Financing Activities -63
181
64
Above figures are in Rs. Crores % Holding Dec 2024
Jul 2025
Promoter 77.23 %
74.69 %
FIIs 0.00 %
0.00 %
DIIs 0.00 %
3.35 %
Government 0.00 %
0.00 %
Public / Retail 0.00 %
13.18 %
Others 22.77 %
8.78 %
No of Share Holders 16
8,25,844